Benzinga | Oct 25, 2021 06:41AM EDT

DarioHealth Announces Contract With A US National Employer To Provide Its Full Multi-Condition Suite Digital Therapeutic Solutions; Size Not Disclosed

DarioHealth Corp. ("Dario," "DarioHealth" or the "Company") (NASDAQ:DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into a contract with a U.S. national employer (the "Employer") for the Company's full multi-condition suite of chronic condition management solutions, including diabetes, pre-diabetes, hypertension, musculoskeletal, behavioral health, and digital employee assistance programs. Enrollment of the Company's multi-condition suite of chronic condition management solutions is expected to begin in the first quarter of 2022, consistent with the Employer's benefit year.